Novartis Ag (NVS) Dividends Paid - Common (2009 - 2025)
Novartis Ag (NVS) posted Dividends Paid - Common of -$2.5 billion for Q2 2025, up 67.41% sequentially from -$7.6 billion in Q4 2024, and down 2.81% YoY from -$2.6 billion in Q2 2024.
Novartis Ag (NVS) Dividends Paid - Common (2009 - 2025) Analysis & Trends
Novartis Ag (NVS) has 9 years of Dividends Paid - Common data on file, last reported at -$2.5 billion in Q2 2025.
- Quarterly Dividends Paid - Common fell 2.81% year-over-year to -$2.5 billion in Q2 2025, while the trailing twelve-month figure through Jun 2025 was -$19.8 billion (up 19.41% YoY) and the FY2025 annual result came in at $7.8 billion, up 2.54% from the prior year.
- Dividends Paid - Common climbed to -$2.5 billion in Q2 2025 per NVS's latest filing, from -$7.6 billion in the prior quarter.
- The five-year high for Dividends Paid - Common was -$2.4 billion in Q2 2024, with the low at -$7.6 billion in Q4 2024.
- Average Dividends Paid - Common over 5 years is -$5.8 billion, with a median of -$7.3 billion recorded in 2021.
- Year-over-year, Dividends Paid - Common dropped 5.45% in 2021 and grew 3.34% in 2023.
- Novartis Ag's Dividends Paid - Common stood at -$7.4 billion in 2021, then decreased by 1.87% to -$7.5 billion in 2022, then advanced by 3.34% to -$7.3 billion in 2023, then slipped by 5.09% to -$7.6 billion in 2024, then soared by 67.41% to -$2.5 billion in 2025.
- Business Quant data shows NVS's Dividends Paid - Common at -$2.5 billion in Q2 2025, -$7.6 billion in Q4 2024, and -$2.4 billion in Q2 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dividends Paid - Common (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,066.16 Bn | 1,060.88 Bn | 16.22 Bn | 1.55 Bn |
| 2 | Johnson & Johnson | 611.69 Bn | 589.64 Bn | 15.96 Bn | 3.13 Bn |
| 3 | AbbVie | 444.34 Bn | 434.99 Bn | 10.78 Bn | 3.09 Bn |
| 4 | Astrazeneca | 284.94 Bn | 277.05 Bn | 12.61 Bn | -3.29 Bn |
| 5 | Merck | 224.23 Bn | 218.58 Bn | 12.09 Bn | 2.11 Bn |
| 6 | Amgen | 195.12 Bn | 183.08 Bn | 5.87 Bn | 1.36 Bn |
| 7 | Gilead Sciences | 156.45 Bn | 148.73 Bn | 5.52 Bn | 1.04 Bn |
| 8 | Pfizer | 136.01 Bn | 123.24 Bn | -1.21 Bn | 2.45 Bn |
| 9 | Novartis Ag | 113.45 Bn | 113.67 Bn | - | - |
| 10 | Biogen | 30.87 Bn | 26.59 Bn | 1.82 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | -2.49 Bn |
| Jun 30, 2025 | -2.49 Bn |
| Dec 31, 2024 | -7.62 Bn |
| Dec 31, 2024 | -7.62 Bn |
| Jun 30, 2024 | -2.42 Bn |
| Jun 30, 2024 | -2.42 Bn |
| Dec 31, 2023 | -7.26 Bn |
| Dec 31, 2023 | -7.26 Bn |
| Dec 31, 2022 | -7.51 Bn |
| Dec 31, 2022 | -7.51 Bn |
| Dec 31, 2021 | -7.37 Bn |
| Dec 31, 2021 | -7.37 Bn |
| Dec 31, 2020 | -6.99 Bn |
| Dec 31, 2020 | -6.99 Bn |
| Jun 30, 2013 | 6.00 |
| Jun 30, 2013 | 6.00 |
| Dec 31, 2012 | -6.03 Bn |
| Dec 31, 2012 | -6.03 Bn |
| Jun 30, 2012 | -20.00 |
| Jun 30, 2012 | -20.00 |